Dechra Veterinary Products has launched Sporimune (ciclosporin), licensed for the treatment of chronic manifestations of atopic dermatitis in dogs.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "Around 20% of all small animal consultations involve skin conditions and canine atopic dermatitis can be challenging to diagnose and manage effectively.
"Although incurable, atopic dermatitis can be managed using a multimodal approach which is likely to include treatments to decrease pruritus as well as allergen identification, avoidance where possible and improving skin and coat hygiene."
Sporimune is a 50 mg/ml oral solution administered by syringe, which is graduated to show both bodyweight and ml. Dechra says it is being introduced to veterinary professionals within the company's Partners in Practice programme which aims to support vets and vet nurses as they diagnose, control and maintain complex dermatological conditions.
Mr Brown added: "It is critical that owners are fully involved and educated about their pet's condition for dogs to be treated effectively. So we have also developed support materials around the use of Sporimune for practices, including client information leaflets and a video on how to use the dosing syringe."
Sporimune is now available from veterinary wholesalers. For further information visit www.dechra.co.uk/sporimune.
Petplan is giving away a VIP trip for two people to this year's 'Petplan Veterinary Awards' in Birmingham on 31st March.
The prize includes two admission tickets to the awards ceremony, as well as accommodation at a top hotel in Birmingham.
Veterinary staff can be in with a chance at winning this exclusive opportunity by nominating their practice or a member of staff for the following awards:
Alison Andrew, Petplan's Marketing Manager, said, "Veterinary professionals up and down the country show great commitment and dedication to our pets everyday and the awards are an opportunity to recognise all their hard work. By nominating a colleague you can not only show them your appreciation but you can also going into the draw to win a fantastic night out"
By making a nomination at www.petplan.co.uk/vetawards you'll automatically be entered into the draw to win the VIP tickets to the evening.
Nominations for the awards close on the 4th February and the winner of the VIP tickets will be announced in late February.
The survey is part of an initiative to develop a 'roadmap' for what needs to happen to support veterinary teams to deliver contextualised care and shared decision-making.
The survey will be used alongside interviews with people in a range of roles in the veterinary sector, including veterinary receptionists and practice managers, to gather insights about what makes it easier or more difficult to practise contextualised care and what could help support its delivery.
Pet owners will also be surveyed and invited to focus groups to understand what matters most to them when making decisions about their pets’ health, and what would help them to feel supported to decide the veterinary care that is right for them and their pet.
Sally Everitt, Clinical Lead – Evidence at RCVS Knowledge, said: “Although the term contextualised care is now being widely used, and a requirement to practise contextualised care is included in the RCVS Guidance for veterinary surgeons and veterinary nurses, there is little information available on how contextualised care is most effectively delivered in practice.
"Our research aims to address a gap in the evidence about what the barriers and enablers are and what needs to change to support veterinary teams to deliver contextualised care.”
The survey is open to veterinary surgeons currently in clinical practice in the UK working with dogs and cats.
The survey can be accessed here until 17th April 2025: https://survey.alchemer.eu/s3/90806393/rcvskresearchprofessionals
Photo: www.depositphotos.com
The study1 suggests that dogs with uncomplicated diarrhoea do not need antibiotics as part of their veterinary care plans.
The study included a random sample of 894 dogs aged between three months and 10 years old diagnosed with uncomplicated diarrhoea in 2019.
Of these, 355 (39.7%) dogs were prescribed antibiotics, and 539 (60.3%) dogs were not prescribed antibiotics (with or without additional supportive treatment) at first presentation for diarrhoea.
For the analysis, the dogs were balanced for a range of other differences between the groups including age, breed, bodyweight, insurance status, the presence of two or more medical conditions, vomiting, reduced appetite, blood in faeces, raised temperature, duration of diarrhoea, additional treatment prescription and veterinary group.
The researchers say this effectively meant that the only difference between the two groups was that one group received antibiotic treatment while the other did not.
The likelihood of clinical resolution of diarrhoea in the dogs prescribed antibiotics was 88.3%, compared with 87.9% in dogs not prescribed antibiotics.
This tiny difference of 0.4% between the groups was not statistically significant, leading to the conclusion that antibiotic treatment did not cause any beneficial effects in the treatment of uncomplicated diarrhoea in dogs.
Almost nine in 10 dogs with uncomplicated diarrhoea recovered after a single veterinary visit regardless of antibiotic treatment.
As an additional analysis, the study also explored gastrointestinal nutraceuticals (products derived from food sources that aim to restore digestive health such as probiotics and prebiotics) for treatment of uncomplicated diarrhoea in dogs.
Gastrointestinal nutraceutical prescription (with or without other supportive treatment) at first presentation of uncomplicated diarrhoea caused no statistically significant difference in clinical resolution compared to dogs not prescribed gastrointestinal nutraceuticals.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Diarrhoea is a common condition in dogs and is often treated with antibiotics.
"However, this study highlighted that antibiotic prescription at first presentation of diarrhoea caused no difference in clinical resolution.
"Therefore, this arms veterinarians with the evidence-base for restricting antibiotics for uncomplicated diarrhoea in dogs, and owners should be prepared to only have an antibiotic prescription if absolutely necessary.”
Fergus Allerton, project lead for the PROTECT ME guidelines and co-author of the paper said: “Rational antimicrobial use is critical to defend ourselves and our pets against the growing threat from antimicrobial resistance.
"This study provides vital evidence to strengthen recommendations to withhold antibiotics when treating dogs with acute diarrhoea. Knowing that the outcome will be the same without antibiotics should reassure veterinarians to adopt this approach consistently.”
Reference
Burgess Pet Care, which organises the event, is encouraging vets and nurses to watch the webinars to ensure they’re aware of the key information concerning this year’s Rabbit Awareness Week, Protect and Prevent campaign, taking place from the 1st to the 9th June.
The webinars are hosted by Dr Richard Saunders BSc (Hons) BVSc FRSB CBiol DZooMed (Mammalian) DipECZM(ZHM) MRCVS, veterinary adviser to the Rabbit Welfare Association & Fund (RWAF).
Richard said: "These webinars provide information across all of the key areas relating to preventative healthcare in rabbits. There is a large number of health issues facing rabbits but thankfully many of these can be prevented. Vets play an incredibly important role in ensuring rabbit owners have all the information they need to correctly care for their pets but unfortunately there is still a lack of awareness and understanding around many basic needs such as diet, husbandry and the importance of vaccinations to protect against dangerous diseases.
"The webinars have been designed to be accessible and engaging to all vets and nurses, regardless of their experience level. We’re urging vets and nurses to watch all three seminars so they’re able to provide the best possible advice to rabbit owners seeking advice on their pets in advance of Rabbit Awareness Week."
To watch the webinars and learn more about this year’s Rabbit Awareness Week campaign, visit: www.rabbitawarenessweek.co.uk, where you can also request a free vet pack to help promote any activity you're planning for RAW.
Interestingly, the survey of 2000 people found that men were 11% more likely than women to change their veterinary surgery if they didn't like the look of the masks. There were also geographical variations in the levels of concern about masks, with Londoners (48%) and people from the South West (46%), the North East (41%) and the West Midlands (41%) being most concerned.
Still, there is some consolation for any practice that is using sub standard masks: 78% of UK adults wouldn’t know how to tell if a face mask was fake.
However, 26% of respondents said they would ask their vet to prove their medical grade face mask meets the certified standard and 22% of pet owners said they would expect their vet to wear a medical grade face mask during routine checkups for the foreseeable future.
James Kinsella, Director at Bluetree Group, said: “During such an unprecedented time, it’s no surprise that people are worried about the use of face masks. It is clear that the public has strong feelings about the quality of face masks in practices, with a third of pet owners saying they are worried about the standard of their vet’s face mask. It’s encouraging to see that where expectations are not met, people will seek an alternative.
"The majority of people admit they would not be able to identify a fake face mask, however it is encouraging that a third of those we spoke to would have the confidence to take action and change their vet if they didn’t think their face mask was up to standard."
For more information on Bluetree Group’s face masks, visit: https://bluetreemaskbox.co.uk.
Avacta has announced the launch of Natural VetCare Prescribed, a new range of veterinary exclusive nutraceutical skin and joint supplements.
The range is manufactured in the UK by Natural VetCare and includes four products in total.
Avacta’s commercial manager, Hayley Booth, said: "Cani Flex is designed to support the body’s anti-inflammatory response with a powerful antioxidant formula, which rebalances the system by addressing excess free-radical build up around the joint following injury or wear and tear. Cani Flex Senior also targets joint, heart and brain health and encourages increased activity.
"With allergies becoming more and more prolific, Cani Skin and Feli Skin target one of the most complex issues facing vets and pet owners in today’s environment. The formulations are designed to resolve the body's hypersensitivity by balancing the immune response.
Hayley added: "To ensure veterinary exclusivity, the unique dispensing method has been thoroughly researched and trialed. The easy-to-feed sprinkle capsules sold in individual gold foil pouches are not for sale individually, and boxes of pouches are available direct from veterinary wholesalers only."
For more information, visit avactaanimalhealth.com/NVCPrescribed, contact your Avacta territory manager or call customer services on 0800 8494 550.
Kate’s election means that, come July and subject to ratification by RCVS Council, the offices of RCVS President, Senior-Vice President and Junior Vice-President will all be held by women for the first time in the College’s 177-year history.
A graduate of Edinburgh’s Royal (Dick) School of Veterinary Studies, Kate was a farm vet for 15 years, a partner in a 15 vet practice in Aberdeen. She then moved to the pharmaceutical industry as a veterinary advisor before joining the Department for Environment, Food & Rural Affairs (Defra). From there, she moved into non-veterinary Senior Civil Service (SCS) roles in several Whitehall departments including the Cabinet Office and the Ministry of Justice. As a senior civil servant she was Principal Private Secretary to three Secretaries of State for Scotland, handling a diverse policy portfolio and working across Whitehall, including No.10 Downing Street and the Devolved Administrations.
First elected to RCVS Council in 2015 for a four year term and again in 2020, Kate has previously served as Chair of the RCVS Standards Committee and RCVS representative on the UK co-ordination group for the Federation of Vets of Europe (FVE). Currently Vice Chair of the Education Committee, member of the Registration Committee and the Environment & Sustainability Working Party, Kate is an appointed veterinary member of Veterinary Nurses’ Council.
Kate is a qualified Official Veterinarian (OV), a Non-Executive Director on the Moredun Foundation and Scottish Agriculture College (SAC) Commercial Boards, a veterinary advisor on a Scotland’s Rural College (SRUC) mental health project and on the Council of the Association of Government Veterinarians. She’s a member of the British Veterinary Association (BVA) and the Veterinary Public Health Association. A Council member of the British Cattle Veterinary Association (2004-10), Kate served as a Trustee of the BVA Animal Welfare Foundation (2014-17).
Current RCVS President Dr Mandisa Greene will become Senior Vice-President, and joining Kate and Mandisa on the Officer team will be Dr Melissa Donald, who last month was elected Junior Vice-President for 2021-22. Current Senior Vice-President Dr Niall Connell was recently elected RCVS Treasurer.
The vacancy in the RCVS Officer team arose following Professor David Argyle’s decision to resign from Council in March, meaning that Council needed to hold two votes in quick succession: one at its scheduled meeting in March for the 2021-22 JVP position; and one today for the current JVP vacancy.
Kate said: “I am delighted to be elected JVP. It’s been an exceptionally challenging year for those in all walks of veterinary life, including students aspiring to join our profession. It will be an honour to lead the RCVS as its tenth female president, working with veterinary colleagues as well as reaching out to allied professionals acknowledging that there will be challenges to navigate as well as triumphs to celebrate.”
Over 25% of the 1001 veterinary professionals who responded felt that the use of technology for triage and or consultations had either improved efficiency or the service offered to clients.
More than 10% said the pandemic had led to practices taking actions which streamlined client processes such as taking payments and booking appointments online or by phone.
The survey results are included in a presentation at the BSAVA Virtual Congress: "Lessons from Lockdown:Telemedicine is here to stay", which forms part of the current topics stream on Saturday 27th March. Brian Faulkner will take a look at maintaining relationships and changing dynamics with remote consults, communication challenges and opportunities. Matt Flann will follow with: "A practical perspective – how we have used it, what have we learned?"
BSAVA President Professor Ian Ramsey said: “The survey results have given us an important insight on how technology is being deployed to help the profession continue to help pets and their owners safely and to the best of their ability in these difficult circumstances.
"Vets have embraced innovations in practice such as telephone triage, remote consultations and digital communications. These have shown us that, as within the human healthcare sector, we can continue to deliver our vital services, possibly to an even more efficient and effective standard, despite the restrictions.
"Our Congress session on lockdown learnings promises to make for compelling listening with important ramifications for veterinary practice even after the pandemic has receded to a bitter memory. As we return to degrees of normality these innovations should not be discarded, but equally must not be allowed to generate the inequalities that go hand in hand with them if some practices and owners are inadvertently left behind.”
To register for BSAVA Congress, visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
MMI seeks to address mental health and wellbeing issues within the veterinary profession, while the Doctors’ Support Network provides peer support for doctors and medical students with mental health concerns.
&me was launched this time last year at the Palace of Westminster at an event sponsored by Kevan Jones MP (Labour, North Durham,) who has spoken about his own experiences with depression.
Overall eleven &me ambassadors have volunteered their own stories with mental ill-health:
A number of &me ambassadors will be taking part in an ‘&me live’ session at BSAVA Congress, from 5-8 April 2018 in Birmingham, providing a short overview of their story before taking questions from the audience. The session will take place from 8.30 to 10.10am on Saturday 7 April and will be open to all those attending Congress.
Lizzie Lockett, RCVS CEO and Mind Matters Director, said: "The feedback our &me ambassadors have received is truly heartening.
"Steve Carter, for example, had both an ex-student and colleague comment on his story thanking him for all he’s done, while a Facebook post about Rob Pettitt reached nearly 25,000 people.
"The campaign highlights how it is possible to recover from mental ill-health and flourish in your career, with the aim of encouraging those at the start of their mental ill-health experience to seek appropriate help, whether that is something profession-specific, such as Vetlife or DSN, or their GP."
Louise Freeman, Co-Chair of the DSN, added: "Many healthcare professionals face similar pressures that can lead to mental ill-health, including long hours, intense pressure, and the nature of the job which requires practitioners to constantly provide care for others, without necessarily recognising the need for self-care at the same time.
"A recurring theme that we’ve seen from these ambassadors’ stories has been that they drew on support from friends and family, and we really hope that this campaign encourages other professionals to seek help if they feel they are struggling."
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health.
To participate in the campaign, email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me, and a blog by Louise, 'Me and #AndMe', can be found at www.vetmindmatters.org/me-and-andme/.
Vetoquinol UK has launched Dolpac®, its new wormer for dogs.
Dolpac® is a broad spectrum anthelmintic for dogs containing pyrantel, oxantel and praziquantel. Individually these ingredients are effective against individual worm species and the combination of all three provides specific activities against the most common roundworm and tapeworm species.
According to the company, clinical studies carried out in accordance with internationally recognised guidelines have shown that Dolpac® provides an excellent ability to reduce parasitic infection.
“Dolpac® offers vets and their clients an easy to use worming alternative at an affordable price,” explains Mark Leddy, Vetoquinol’s Marketing Department Manager. “Our aim is to help to increase the number of dog owners worming their pets at the correct frequency, which will not only protect their dogs, but their children as well. We have introduced a number of features to help achieve this objective, there are three tablet sizes to cover all weight ranges and the tablets are flavoured and easy to give, and there are dispensing envelopes in every pack. We also provide a dosing wall chart and a client worming guide.”
For more information, contact your Vetoquinol representative or visit the Dolpac website, http://www.dolpac.co.uk/, which offers information for both vets and clients.
Novartis Animal Health has launched Zolvix, billed as the first truly novel anthelmintic class for livestock to be launched in more than 25 years, together with a new drenching system designed to make drenching faster, easier and more accurate.
Zolvix contains a new active ingredient, monepantel, which kills all key sheep gastro-intestinal nematodes (roundworms), including those resistant to the existing treatments.
According to the company, the development of this new drench follows the persistent challenge from worms that have developed resistance to the three other classes of drench - white (benzimidazole or 1-BZ), yellow (levamisole or 2-LV) and clear (macrocyclic lactone or 3-ML) and combinations of these. Zolvix has a unique mode of action and so forms a fourth generation of anthelmintic, which will be known as the 4- AD, or orange drench class
Novartis Animal Health has prioritised the UK and Ireland as key launch countries for Zolvix to provide their sheep farmers with an answer to the pressing challenge of increasing anthelmintic resistance.
Lesley Stubbings, an Independent sheep consultant and Sustainable Control of Parasites in Sheep (SCOPS) panel member, said: "Resistance has become an ever increasing threat since the last new anthelmintic group was introduced to the UK market more than 25 years ago. Zolvix offers farmers a valuable opportunity to maintain good worm control and prolong the effective life of the existing products. Following the SCOPS guidelines to carefully integrate Zolvix into worm control strategies, before the other groups fail, will allow our sheep industry to reap the full benefits of this new novel group."
A study carried out by Novartis in conjunction with the Hopkirk Research Institute showed that Zolvix treated sheep gained 33.5%, or 2.8 kg deadweight, more than sheep treated with a drench to which they were resistant.
Novartis Animal Health Brand Manager Simon Harris said: "Parasite resistance is a growing problem that decreases the productivity of sheep of all ages. Many veterinarians and farmers are concerned about this, with an increasing number of farmers reporting resistance to the three groups of wormers that have been available up to now, so the introduction of Zolvix is very timely."
At the same time, the company has also launched an award-winning new drenching system designed to offer 'a superior drenching experience for both animal and operator'. The new Optiline Drencher and Optivix backpack system were developed in collaboration with drenching specialists Simcro Tech Ltd.
The Optiline Drencher has already won several design and engineering awards, including a bronze award in the 2009 NZ BEST design awards, a coveted International Forum (IF) 2010 product design award from Germany and the prestigious Bayer Innovators Award for design and engineering.
It was also a finalist in the New Zealand Agritech Innovation Awards reached the finals in three categories of the 2009 New Zealand Trade and Enterprise International Business Awards.
The Optiline drencher is coupled with a durable, light Optivix backpack that has been specially tailored to provide left or right-handed operators with the same wide range of adjustment. It also has two drench cradles - at chest and hip level - to ensure maximum comfort.
Mr Harris said: "This drencher is best appreciated during use. Contact your local Novartis Animal health representative to arrange a trial."
Compiled by global higher education analysts, QS Quacquarelli Symonds, the rankings provide a comparative analysis on the performance of 14,435 individual university programs, taken by students at 1,452 universities in 86 locations around the world, across 51 academic disciplines and five broad Faculty Areas. The rankings are determined by a range of criteria, including academic reputation, research impact, number of citations, employer reputation and the h-index.
In addition to maintaining a perfect score for the Academic Reputation indicator (100) for a second year running, the RVC saw improvements across every category. Research impact was recognised with the RVC scoring 98.9 in Citations per Paper. This was supported by the 97.5 score for h-index, surpassing 2020’s 96.9.
Rankings for Employer Reputation also increased by 29% since 2020, with the RVC now scoring 83.3.
Professor Stuart Reid, Principal of the RVC, said: "Last year, we made a commitment to redouble our efforts in seeking to regain the top spot in the QS rankings, and I am delighted that we have achieved it. This would be remarkable in normal times but, in the context of COVID-19, it is all the more so and a real tribute to the whole RVC community.
"It is the result of enormous efforts made by all RVC staff and students, and I could not be prouder to be Principal of the RVC. The QS rankings are important for our reputation and international standings. With so many outstanding veterinary schools worldwide and with peer recognition one of the metrics, it is particularly pleasing to be first amongst equals."
The full set of rankings can be found at: https://www.topuniversities.com/subject-rankings/2021
Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
Procapen contains a high dose of procaine benzyl penicillin, a narrow spectrum antibiotic which targets the most important pathogens in fresh cases of mastitis in cows and is the drug of choice against benzylpenicillin-susceptible streptococci and staphlococci.
Marcus Scott, Large Animal Business Manager at Forte said: "With the widespread shortage of intramammary tubes at the moment, Procapen provides a welcome solution for many mastitis cases."
For more information, contact your local Forte Territory Manager or email: enquiries@fortehealthcare.com.
The webinar, titled 'Creating a positive relationship with cats and their owners in practice', will take place at 8pm on Wednesday 20 November. It will cover understanding of the cat’s natural behavioural patterns and their influence on feline behavioural responses, which are essential in order for veterinary professionals to effectively handle feline patients.
It will also feature advice on how to see things from a feline perspective and consider ways in which confrontational encounters can be prevented. This, says Ceva, is essential for creating a positive relationship with cats and their owners in the practice environment.
To register for the webinar, which accounts for one hour’s CPD, email: cevauk@ceva.com with your full name, practice name and postcode and the name of the webinar.
The link needed to watch the webinar will be sent back via email.
Ceva says that due to high demand, this webinar will be on a first come, first served basis. The company also recommends that delegates log in via the link in good time on the night to ensure a place.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and due to be validated by Harper Adams University, Improve says the new Cert will be delivered over 14 modules in three blocks of training by globally recognised experts in practical training centres in Sheffield, UK; Cremona, Italy and Madrid, Spain.
The modules will be supported by an online learning platform providing notes, additional learning resources and the ability for delegates to discuss clinical cases in a closed forum.
David Babington MRCVS, Business Development Director at Improve International, said: "Our GPAdvCert in Small Animal Soft Tissue Surgery is a natural progression for veterinary surgeons who want to develop their soft tissue surgery skills.
"The programme focuses on problem-solving to increase confidence in diagnosing and stabilising animals with complex pathologies and delegates will have plenty of opportunity to practise new surgical techniques and advanced procedures under close supervision in a wet-lab environment."
He added: "In common with our other GPAdvCerts in Orthopaedics and Small Animal Medicine, achieving this qualification will help vets in practice to reduce the number of patients they have to refer, enabling them to retain a higher level of income for their practice. The programme will also provide them with skills which they can pass onto their team."
The GPAdvCert in Small Animal Soft Tissue Surgery is aimed at veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Surgery (GPCertSAS) or a Postgraduate Certificate (PgC) in Small Animal Surgery.
Improve says the successful achievement of a GPAdvCert enables delegates to progress from a Postgraduate Certificate (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Master’s Degree (MSc) in Advanced Veterinary Practice Sciences.
Medivet, the practice group which is to feature in the forthcoming Panorama documentary It shouldn't happen at a vets' (9pm, July 22nd), has issued a statement concerning the programme.
The statement, which can be read in full here, includes an interview with a Medivet client who was in turn interviewed for the documentary:
There are nine candidates standing in this year’s elections, including five existing Council members eligible for re-election and four candidates not currently on Council. They are:
Dr Linda Belton MRCVSAt a glance: Equine clinician. Director of George Veterinary Group, a 40-vet independent practice. Wants to safeguard veterinary surgeons' clinical freedom and prevent it being eroded as a result of corporatisation.
Dr Niall Connell MRCVSAt a glance: After a career largely in small animal charitable practice, Niall had to retire from clinical practice as a result of MS. Has been a council member since 2013 and now RCVS President-elect. By all accounts, something of a national treasure. Wants the College to: "regulate compassionately in partnership with our profession".
Mr John C Davies MRCVSAt a glance: Small animal practitioner who, having had his fingers burned in a failed joint venture arrangement and parts of his election manifesto redacted by the RCVS (it can be read in full here: http://www.johndaviesvet.com), now campaigns for justice, integrity, accountability, freedom of speech and due diligence at the College and in the wider profession.
Dr Joanna (Jo) Dyer MRCVSAt a glance: Small animal locum practitioner who was first elected to council in 2015 after successfully lobbying for changes to the CoPC Guidance following Chikosi. An all round good egg. Argues passionately against changes to the Code of Conduct to allow remote prescribing of POM-Vs.
Professor Timothy (Tim) Greet FRCVSAt a glance: Widely-published equine practitioner and past-pres of BEVA, BVA and WEVA. In favour of RCVS regulation of para-professionals. Argues that whilst technology is to be welcomed, diagnosis and prescribing must be restricted to animals 'under our care'.
Professor John Innes FRCVSAt a glance: RCVS Specialist in small animal orthopaedics (with 85 peer-reviewed papers to his name) and Referrals Director at CVS. Pledges to speak as an independent veterinary surgeon - not a corporate representative - if elected. On record as being pleased that the proposed RCVS telemedicine trial was delayed pending further consultation. In favour of 'nurse practitioner' becoming a regulated option for RVNs.
Dr Thomas (Tom) Lonsdale MRCVSAt a glance: Single-issue candidate with a 23-year history of standing for election to draw attention to the supposed evils of commercial pet foods. Based in Australia. 2000-1 outsider.
Dr Katherine (Kate) Richards MRCVSAt a glance: 15 years in farm animal practice before taking up various positions in industry and government. Champions a healthy work-life balance, fair pay, workplace flexibility and supportive work practices.
Mr Peter Robinson MRCVSAt a glance: A long career in independent farm, equine and small animal practice, followed by a stint in sole practice in Dubai. Has been on Council for 4 years. Like Jo Dyer, argues that when it comes to remote prescribing and telemedicine, "we must not change the standards of ‘under our care'."
Ballot papers and booklets containing candidates’ details and manifestos have been sent by post to all veterinary surgeons eligible to vote and an email containing a unique link to a secure voting site has also been sent by Electoral Reform Services, which runs the election on behalf of the College.
All votes must be cast, either online or by post, by 5pm on Friday 26 April 2019.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "Last year we saw another very strong turnout for the RCVS Council election with over a fifth of the profession casting votes. The turnout was again helped by regular email reminders and the fact the voting website can be easily accessed by just clicking on a link.
"I would like to remind the profession that, following last year’s changes to our governance structure after a Legislative Reform Order was passed through Parliament, you can now only choose up to three candidates. I do hope members of the profession take this opportunity to influence the governance and policies of the RCVS."
Those who are eligible to vote but have not received either an email or ballot paper should contact Luke Bishop, RCVS Senior Communications Officer, on l.bishop@rcvs.org.uk.
Defra has confirmed that equine infectious anaemia (EIA) has been detected in two horses in Wiltshire following importation from Romania via Belgium.
The premises is currently under restriction and the two infected horses will be humanely destroyed in line with existing regulations. The other horses on the premises will be subject to epidemiological investigation in the coming weeks. A further two horses have also been under investigation and test results have proved negative.
The animals arrived in a group of 10 horses, nine of which originated from Romania and one from Belgium. The nine Romanian horses were tested for EIA as part of routine post-import testing. Seven horses all tested negative. The horse that originated in Belgium is due to be tested shortly.
Chief Veterinary Officer, Nigel Gibbens said: "This is the first case of equine infectious anaemia infected animals being imported into Great Britain since 1976 and shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy these two horses that tested positive."
The BSAVA has announced the launch of its third smartphone app - the BSAVA Small Animal Formulary App.
This member-only access app is available to download now from iTunes and Android Market and offers the same reference materials found in the latest 7th edition printed version.
The BSAVA says the app contains more than 450 drug monographs and a wealth of additional information, allowing easy and rapid access to vital information about those medications that veterinary surgeons most commonly prescribe. It is hoped that the convenience of having the BSAVA Small Animal Formulary on a smartphone will mean that vets in practice will always have this valuable reference tool within easy reach.
Once the app is installed it will ask for a validation code that can be obtained from the smartphone app validation code page within My BSAVA pages at www.bsava.com. All future BSAVA member-only smartphone apps will be validated using the same process.
BSAVA IT Manager Emma Hayes said: "BSAVA is continually aiming to provide a range of valuable member benefits in a variety of formats so they can be used in the most efficient and effective way by our members. The BSAVA Formulary was a natural candidate for release as a mobile application, following the successful launch as an online searchable database at Congress in April. By developing this application it has also provided us with a platform that will enable us to produce additional useful applications in the future that can provide unrestricted content for our members."
The BSAVA Small Animal Formulary App follows on from the BSAVA Congress App and the BSAVA Guide to the use of Veterinary Medicines App. You can find out more about these other BSAVA smartphone apps through My BSAVA at www.bsava.com.
The new series comprises six online discussions taking place over the course of the spring, covering everything from diversity to creativity to identity.
The upcoming programme of events is as follows:
Tuesday 1st March 2022 7pm to 8pm: Celebrating diversityChaired by Gurpreet Gill, RCVS Leadership & Inclusion Manager. Panel members Lacey Pitcher RVN, Dr Olivia Anderson-Nathan MRCVS and Samantha Payne RVN will be talking about what celebrating diversity means to people, exploring how this links to mental health, and sharing their thoughts on why – and how – the professions should be working towards greater inclusivity, both in and out of the workplace.
Monday 21st March 2022 7pm to 8pm: The joy of creativityThis discussion will look at why creativity is so important for people’s lives and how it can be used to support mental health and wellbeing with a panel comprising Dr Silvia Janksa MRCVS and Olivia Oginska MRCVS.
Tuesday 5th April 2022 7pm to 8pm: Overcoming self-doubt and stressing outThis discussion will consider the main causes of stress in the veterinary workforce and how this may have shifted throughout the pandemic. The discussion will encompass coping strategies, the ways in which stress can be channelled in a more constructive way, and overcoming feelings of self-doubt.
Thursday 21st April 2022 7pm to 8pm: Identity – who am I away from work?This discussion will consider to what extent veterinary professionals should let their careers define them, the importance of understanding oneself in and out of a work setting, and how people can learn to value, accept, and appreciate their whole selves.
Tuesday 3rd May 2022 7pm to 8pm: Saying goodbye…letting go and learning to growThis discussion will consider how best to cope with the various types of loss that may be encountered in an individual’s professional and personal life, and how to learn, adapt and grow from these losses.
Thursday 12th May 2022 7pm to 8pm: Tackling loneliness in a hyperconnected worldThis Campfire Chat will discuss why meaningful connection and having a sense of belonging matters, and how individuals and communities can tackle loneliness in a hyperconnected world.
Angharad Belcher, Director of the Mind Matters Initiative, said: “We all lead busy professional and personal lives and sometimes it means that self-care, which includes talking to others about how we’re feeling and about issues that we find important to us, can fall by the wayside.
“Our Campfire Chats offer a perfect opportunity – and excuse – to take a bit of time out of your schedule to engage in a structured but informal discussion about all manner of subjects, expertly led by a chair and panel with experience, lived and otherwise, on the topic being talked about.
“These events are for the whole veterinary team, we keep the sessions very informal, and there is also the opportunity to share or ask questions of the panel.”
To sign up for the first session, visit https://bit.ly/3GnQK0G.
For further information about the events contact Abi Hanson, Mind Matters Initiative Officer, on a.hanson@rcvs.org.uk
The survey of 2717 horse owners, 56% of which were leisure owners and 35% professionals, found that most horses (62%) were retired between 15-24 years of age, mainly for health reasons.
Mares had a higher risk of retirement than geldings, which the researchers say may be due in part to mares used for breeding not doing much structured exercise.
Just over 1 in 6 horses in the study were affected by low muscle mass according to their owners.
Age, sex, osteoarthritis, laminitis, pituitary pars intermedia dysfunction (PPID), and primary use were identified as risk factors for low muscle mass.
Geldings had a higher risk of low muscle mass than mares, which the researchers say may be a result of low testosterone.
Horses with owner-reported veterinary-diagnosed PPID, osteoarthritis and laminitis had a higher risk of low muscle mass.
Primary use was identified as a risk factor for low muscle mass, with retired horses having a higher risk than horses used for competition or pleasure riding.
Owner-reported low muscle mass was perceived to affect welfare and the ability to work in the majority of senior horses.
Alisa Herbst, who led the study, said: “A prolonged working/active life may not only be desired by owners but is also likely to provide health and welfare benefits to the horse.
"We hope the results of this study may be useful for veterinarians caring for senior and geriatric equines, by helping to achieve this."
“The information may aid in the investigation of diseases affecting senior horses and in establishing senior horse-owner education programs.
"The low muscle mass risk factor list may assist vets in identifying horses at risk of low muscle mass to be selected for close monitoring.
“Vets may also consider inclusion of an objective measurement of muscle atrophy, such as the muscle atrophy scoring system (MASS)***, in annual wellness exams, so that atrophy can be identified and managed as early as possible."
Sarah Nelson, Product Manager at Mars Horsecare added: “This survey has highlighted several interesting retirement trends.
“With a better understanding of when and why senior horses are being retired we hope, eventually, to be better placed to monitor for, prevent (where possible), and treat the underlying conditions early on, to help horses stay active and healthy for longer.”
https://www.seniorhorsehealth.com
At the hearing, the Disciplinary Committee considered whether she had accepted the findings of the Committee at the original inquiry hearing, the seriousness of those findings, whether she had demonstrated insight into her past conduct, and the protection of the public and the public interest.
In her restoration application, Dr Burrows included continuing professional development (CPD) certificates for the courses she had completed since her removal from the Register, letters/informal witness statements from the veterinary surgeons and nurses she had worked who had expressed a willingness to employ her again, together with character references and reflection statements.
She also made a detailed opening statement in support of her application, in which she said that the period since her name was removed from the Register was extremely difficult and also that she now unconditionally accepted all the Committee’s original findings in May 2021, some of which she had previously denied and had failed to acknowledge.
Dr Burrows went on to state that she only had herself to blame for her actions and that she now understood and accepted that the original sanction of removal from the register had needed to be severe given the serious breach of trust to the public, to the veterinary profession and the insurance industry that was a direct consequence of her dishonest actions.
Since removal from the Register, Dr Burrows had taken on the role of receptionist in a Vets4Pets practice in Cardiff, which required her to deal directly with the public and their insurance requests and entitlements.
She stated that as a result of her involvement over the past 18 months in processing insurance claims, she acknowledges the “delicate” relationship between veterinary surgeons, clients and insurers.
Additionally, working as a receptionist, had allowed her to recognise the need for contemporaneous and clear clinical notes.
She also highlighted her CPD, which was relevant to insurance, as well as the fact she’d undertaken a professional ethics course to assist her rehabilitation, reflection, and insight.
In support of Dr Burrows’ restoration to the Register, the Committee took into account three witness accounts from people who work at the Vets4Pets branch where Dr Burrows works as a receptionist.
All witnesses gave positive reflections on Dr Burrows’ character and assured the Committee that they would provide the correct level of support to allow her to return to work safely and that they would have all the necessary safeguarding measures in place to ensure that the public’s and the profession’s interest is always at the forefront.
Judith Way, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee was impressed by the fact that busy professionals chose to give up their time to provide witness statements and give evidence in support of Dr Burrows’ application.
"All witnesses were clearly supportive of Dr Burrows’ request for restoration to the Register.
“The Committee found Dr Burrows to show remorse and she does now accept the findings of dishonesty that were made against her in the original enquiry hearing and stated that her conduct was dishonest.
"In the Committee’s view, the evidence given by Dr Burrows on affirmation was very believable and she now accepts her dishonesty together with the gravity of her dishonesty.
“The Committee also formed the view that the steps she has taken to address her dishonesty serve to confirm that she is passionate about the prospect that she be allowed to return to practise.
"The Committee was impressed by Dr Burrows and the evidence given and is now satisfied that she will ensure the highest standards of probity and honesty in the future.
“Having taken all evidence into account, the Committee is satisfied that the future welfare of animals under Dr Burrows’ responsibility will be properly protected, and that her future dealings with insurers will be honest in all respects and that the interests of the public will be met.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Eurovet Animal Health has announced that its levothyroxine tablet hypothyroidism treatments, Forthyron 200 and Forthyron 400, are now available in a scored snap-tab format that allows the tablet to be broken easily into four equal pieces.
Eurovet says this represents a significant benefit to practices, as individual patients often require varying doses due to differences in absorption and metabolism, requiring a wide variety of strengths of medication to be kept in stock. The new presentation means that veterinary surgeons can provide the accurate, customized, individualised approach that these patients require and since just two strengths need to be stocked, it is easier to manage the dispensary. This saves the practice time and money.
Forthyron contains levothyroxine, a synthetic product, chemically identical to naturally occurring T4 that, due to its long duration of action, is a commonly used treatment for hypothyroidism in dogs.
For further information telephone 01223 257933 or email office@eurovet-ah.co.uk www.eurovet-ah.co.uk